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Summary. Blot hybridization analysis of infected bovine herpesvirus 1 (BHV- 
1) cellular RNA isolated at various times post infection and after treatment 
with specific metabolic inhibitors was used to characterize transcription of the 
BHV-1 Cooper isolate. Synthesis of BHV-1 RNA was detected as early as 3 h 
post infection and reached a maximum at six to eight hours post infection. The 
most transcriptionally active area of the genome was between map units 0.110 
to 0.195, within the HindIII I fragment. From the entire genome a total of 59 
transcripts ranging in size from approximately 0.6 to 10 kilobases were char- 
acterized as belonging to one of three distinct classes. Using the protein synthesis 
inhibitor cycloheximide, three immediate-early transcripts were identified as 
originating from the internal inverted repeat region between map units 0.734 
and 0.842, corresponding to the HindIII D fragment. Using phosphonoacetic 
acid to prevent virus DNA synthesis by inhibition of the BHV-1 DNA poly- 
merase, 28 early transcripts were recognized. The remaining 28 transcripts, 
classified as late RNA, were detected without the use of metabolic inhibitors 
at 6 to 8 h post infection. Transcription of early and late RNA was not restricted 
to any specific area of the genome. Eighty percent of the transcripts from both 
the HindIII A fragment, between map units 0.381 to 0.537 within the unique 
long segment, and the HindIII K fragment, between map units 0.840 to 0.907 
of the unique short segment, were designated as belonging to the early class. 
Introduction 
Bovine herpesvirus 1 (BHV-1), family Herpesviridae, genus Simplexvirus, is 
associated with a variety of clinical syndromes [27, 42, 59]. These are primarily 
respiratory, but also include genital infections, abortion, and encephalitis [8, 
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9, 19, 34, 36, 52]. Infectious bovine rhinotracheitis (IBR) was first described 
in the U.S. as a respiratory tract disease of cattle in 1955 and the virus was 
isolated shortly thereafter [27, 35]. The genital form of the disease known as 
infectious pustular vulvovaginitis (IPV) was described in 1950 in the U.S., but 
has been known in Europe since the middle of the 19th century [19, 21, 23]. 
BHV-1 was first shown to be a DNA virus by replication inhibition in cell 
culture with deoxynucleotide analogues [50]. The viral DNA has a density of 
1.73 g/cm 3, a base composition of 76.7% GC, and a melting temperature of 
82.7°C [15]. During infection of cells in culture, virus DNA synthesis begins 
4 to 6 h post infection 1-46] and extracellular virus appears in the supernatant 
at 6 to 8 h post infection [45, 49]. The genome of BHV-1 is approximately 135 
kilobases (kb) with a unique long segment (UL) of 100kb, an internal repeat 
(IR) of 11 kb, a unique short segment (Us) of 13 kb and a terminal repeat (TR) 
of approximately 11 kb. The Us segment may be oriented in two alternative 
directions, while the UL segment is oriented in only one direction [32]. The 
genomic termini have been cloned and contain short repeats that may vary in 
size. These repetitive sequence elements may be functionally important for 
cleavage and isomerization of virus DNA [17, 18]. 
Polypeptides produced by BHV-1 during infections in cell culture appear in 
a temporally ordered sequence [4, 31, 37]. The alpha or immediate-early genes 
are transcribed in the absence of virus protein synthesis, while beta or early 
gene expression occurs at the start of virus protein synthesis and prior to virus 
DNA synthesis. The gamma or late genes require the onset of virus DNA 
synthesis. Approximately 33 virion polypeptides have been identified ranging 
in molecular weight from 13 k to 275 k; 11 of these proteins can be labeled with 
[3H]-glucosamine and were identified as glycoproteins [37]. 
Several BHV-1 genes have been cloned and mapped to the genome. Like 
herpes simplex virus (HSV), BHV-1 induces its own thymidine kinase (TK) 
during productive infection [22, 54]. The TK gene was subsequently cloned 
and localized by marker rescue to a 1.1 kb BgIII/SalI fragment which maps at 
0.47 to 0.48 on the BHV-1 HindIII A fragment [3]. The TK gene of a wild- 
type BHV- 1 isolate and two TK - mutants have been sequenced. Five conserved 
regions of the BHV- 1 TK gene are homologous with HSV- 1 and -2 and varicella 
zoster virus TK genes [39]. Using a HSV-1 DNA polymerase gene as a probe, 
the BHV-1 DNA polymerase gene was localized within a HpaI/BamHI subfrag- 
ment of the HindIII G fragment [41]. A putative DNA binding protein gene 
was mapped next to the DNA polymerase gene [2]. Glycoprotein gi (gB homo- 
logue of herpes simplex) gene mapped to a 3.8 kb fragment from 0.405 to 0.432 
on the HindIII A fragment of the BHV-1 genome [24, 38, 57]. The glycoprotein 
gIII (gC homologue of herpes simplex) gene has also been cloned, sequenced, 
and mapped between map units (m.u.) 0.122 to 0.135 of the HindIII I fragment 
[12, 13]. Latency associated transcripts of BHV-1 were localized to 0.734 to 
0.748 m.u. of the HindIII D fragment [20, 44]. Transcriptional analysis of 
BHV-1, Jura and K22 isolates, has recently been published. Fifty-four tran- 
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scripts ranging in size f rom 0.4 to greater  than  8 kb were identified by R N A  
blot  hybr idizat ion analysis. F o u r  transcripts were classified as imrnediate-early,  
21 as early, 12 were considered late, and 17 transcripts  could not  be classified 
as early or late using the  metabol ic  inhibi tor  cytosine arabinoside [58]. 
We have found  a number  o f  discrepancies in the sizes o f  the transcripts  
repor ted  previously [58]. Consequent ly ,  we have comple ted  a m o r e  extensive 
analysis using cloned f ragments  representing the BHV-1 Cooper  isolate genome 
to mon i to r  t ranscr ipt ion o f  BHV-1 infected cells temporal ly  and  using metabol ic  
inhibitors.  The Cooper  isolate is the vaccine virus used for BHV-1 in the Uni ted  
States and  has been associated with vaccine- induced epizootics [55, 56]. Tran-  
scription da ta  presented in this repor t  provides compara t ive  da ta  for possible 
differential  gene expression between the Cooper  respira tory and K22 genital 
type isolates. 
Materials and methods 
Cell culture, virus inoculation, virus DNA synthesis, and use of metabolic inhibitors 
Bovine turbinate (BT) or fetal bovine lung (FBL) cells were cultured in Dulbecco's minimum 
essential medium supplemented with 10% fetal bovine serum in 150 cm 2 flasks as described 
elsewhere [47]. The Cooper isolate of BHV-1 [32] used throughout these studies was 
inoculated at a multiplicity of infection of 10. To monitor BHV-1 DNA synthesis, infected 
FBL or BT cells in 25 cm 2 flasks were harvested at various times post infection (p.i.) and 
digested with proteinase K (1 mg/ml) in the presence of sarkosyl (1%) and EDTA (0.1 M, 
pH 8.0). Following phenol-chloroform extraction, 2 gg of infected cell DNA was slot- 
blotted to nylon membranes (Hybond-N, Amersham, Arlington Heights, IL) and baked 
at 80 °C for 2 h [5, 30-1. Virus-infected cell DNA was also isolated at 5 h p.i. in the presence 
of 50, 100, and 150gg/ml cycloheximide (CH) and at 6h p.i. in the presence of 200, 300 
or 400 gg/ml phosphonoacetic acid (PAA). Prehybrid~ation, hybridization with nick-trans- 
lated 32p-labeled BHV-1 DNA and autoradiography were as described in detail previously 
[5, 30, 48]. 
Isolation of RNA and infection protocol 
To determine temporal appearance of BHV-1 transcripts total cell RNA was isolated from 
infected cells at various times p.i. as indicated in the figure legends. Virus-infected cell RNA 
was isolated at 5h p.i. in the presence of 50, t00, and 150 gg/ml CH and at 6h p.i. in the 
presence of 200, 300, or 400 gg/ml PAA to determine optimum concentrations of metabolic 
inhibitors prior to extensive hybridization analysis. Subsequently, for metabolic inhibition 
studies, cells were treated with CH at 100 gg/ml to detect immediate-early transcripts, or 
with PAA at 400 gg/ml, to detect early transcripts. Drug treatment was from two hours 
prior to and throughout infection. Late transcripts were classified as those synthesized in 
the absence of metabolic inhibitors minus the IE and E transcripts. At the designated times 
p.i., cells were rinsed 3 times with ice-cold phosphate-buffered saline (PBS is 0.01 M 
Na2HPO4 and 0.9% NaC1, pH 7.5), followed by lysis with guanidinium isothiocyanate (4 
M guanidinium isothiocyanate, 0. t M ~-mercaptoethanol, 10 mM EDTA, 50 mM Tris-HC1, 
pH 8.2) pipetted directly onto the cell monolayer [6]. A 2.6 ml aliquot of homogenized 
cells was layered over a 1.2 ml cushion of 5.7 M CsC1 (10 mM EDTA, pH 8.0) and centrifuged 
at 160,000 x g for 15 h in a Beckman SW 60 rotor [14]. The RNA pellet was resuspended 
in 10 mM Tris-HC1, 10 mM EDTA at pH 8.2, extracted three times with chloroform- 
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butanol (4:1) and stored at - 70 °C in 2.2 volumes of ethanol with 2 M ammonium acetate. 
Aliquots, 50 ~tl, were pelleted by centrifugation in a cooled (4 °C) microcentrifuge and RNA 
concentrations were determined spectrophotometrically. 
Northern blot hybridization analysis 
Hybridization probes were cloned HindIII fragments of the BHV-1 Cooper genome [32] 
cut from low-melting agarose gels [51]. Two additional cloned fragments, designated HS 
and HK, were derived from the left terminus of the HindIII D fragment and hybridize to 
latency-associated transcripts of BHV-1 [44]. The HS probe corresponds to a HindIII/SalI 
subclone from the HindIII D fragment representing 0.734 to 0.748 m.u. and the HK probe 
is a HindIII/KpnI subclone from 0.734 to 0.778 m.u. of the HindIII D fragment. The EcoRI 
E and F fragments, constituting the termini of the BHV-1 genome [32], were cut from 
low-melting agarose [51] following restriction endonuclease digestion of intact BHV-1 
genomic DNA and agarose gel electrophoresis. Extracted fragments were radioactively 
labeled with [~2P]dCTP and [SzP]dATP (specific activity 3,000 Ci/mmole, ICN Radi- 
ochemicals, Irvine, CA) using the random-primer method [10, 11]. Random-primer (Be- 
thesda Research Laboratories, Gaithersburg, MD) labeled probes of 2 x 10 9 cpmAtg were 
routinely obtained and 1 x 10 6 cpm per lane of electrophoresed RNA was used during 
hybridization. 
Equal amounts of infected cell RNA (6 ~tg) were fractionated by glyoxal gel electro- 
phoresis in 1.0% agarose as described previously [30, 33]. Integrity and RNA concentrations 
per lane were verified by visualization of ethidium-bromide stained RNA during UV trans- 
illumination. Following gel electrophoresis, RNA was transferred to prewetted nylon mem- 
branes by capillary action using 20 × SSC (1 x SSC is 0.14 M NaC1, 0.015 M sodium 
citrate, pH 8.2) and then fixed to the membrane by baking for 2 h at 80 °C under vacuum. 
Filters with immobilized RNA were prehybridized and hybridized in buffer containing 0.5 
M sodium phosphate, pH 7.2, 7% sodium dodecyl sulfate (SDS), 1% bovine serum albumin 
(BSA), and 1 mM EDTA (pH 8.0) at 68 °C [7, 29]. After hybridization overnight, the filters 
with bound probe were washed twice in 40 mM phosphate buffer (pH 7.2), 5% SDS, 0.5% 
BSA, 1 mM EDTA (pH 8.0) for 1 h at the hybridization temperature and twice more in 
buffer with 40 mM phosphate (pH 7.2), 1% SDS and 1 mM EDTA (pH 8.0) for 1 h as 
previously described [29]. Nylon filters with radioactive probes hybridized to immobilized 
RNA were exposed to Kodak XAR-5 film. Sizes of BHV-1 transcripts were determined 
by extrapolation between the relative mobilities of known size markers [25] (Bethesda 
Research Laboratories, Gaithersburg, MD) as designated in the figure legends. Using these 
conditions no cross-hybridization has been detected with bovine cellular RNA (Fig. 4b, 
For quantitation of hybridized cloned probe to blotted infected cell RNA, an Ambis 
radioanalytic imaging system (AMBIS Systems, Inc., San Diego, CA) was used to compare 
differences in BHV-1 RNA production at different concentrations of CH and PAA. This 
was accomplished by placing the blotted infected cell RNA with hybridized radioactive 
probe in the Ambis gas ionization 2-D detector for 16 h. Following the detection period, 
a print-out of the amount of radioactivity per lane of RNA was obtained and compared 
for differences among treatments. 
Results 
Inhibition of  virus DNA replication and determination of  metabolic inhibitor 
concentrations 
To determine op t imum concentra t ions  of  metabol ic  inhibitors,  the effect o f  CH 
and  P A A  on virus D N A  and R N A  synthesis was investigated (Fig. 2). Virus 
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Fig. 1. Genomic structure of the bovine herpesvirus 1 Cooper isolate. Location of the 
HindIII and EcoRI restriction endonuclease cleavage sites, size of fragments and structure 
of the virus genome are illustrated. The genome consists of one unique long (L, UL) section 
and a unique short (S) segment which can occur in reverse orientation with respect to the 
UL segment. Genomic maps were adapted from Mayfield et al. [32] and gene locations 
are as cited in the text 
D N A  synthesis was detected at 4.5 h p.i., reached a maximum at 6.5 h p.i. and 
began to decrease at 8 h p.i. (Fig. 2 A, lane 1). No appreciable D N A  synthesis 
occurred at 5 h p.i. in the presence of CH or at 6 h p.i. in the presence of PAA 
at any of the concentrations used (Fig. 2 A, lane 2). 
Although virus D N A  synthesis was inhibited by CH and PAA at the con- 
centrations used, the amount of RNA present under these conditions was 
unknown. The HindIII  D fragment of BHV-1 D N A  was hybridized with R N A  
from infected cells treated with 50, 100, and 150 txg/ml CH (Fig. 2 B) at 5 h p.i. 
Radioanalytic imaging analysis revealed that the greatest amount  of radioac- 
tivity occurred in the lane containing R N A  purified from infected cells treated 
with 100 gg/ml of CH. Both lanes containing RNA from infected cells treated 
with 50 or 150 gg/ml of CH routinely contained less hybridized radioactivity 
(Fig. 2 B, lanes 1 and 3) than R N A  from infected cells treated with 100 gg/ml 
CH (Fig. 2 B, lane 2). Similar experiments were conducted using R N A  isolated 
from BHV-1 infected cells at 6h  p.i. in the presence of 200, 300, or 400 gg/ml 
of PAA. Infected cell RNA at 6 h p.i. at the different concentrations of PAA 
was analyzed for amount of bound radioactivity following Northern blot hy- 
bridization with the HindIII  I fragment. No observable difference in the amount  
of hybridized radioactivity was detected among PAA treatment groups. Using 
400 ~tg/ml PAA at 6 and 8 h p.i. (Fig. 2 C, lanes 1 and 2) appeared to have no 
effect on detection of early transcripts, and these could be differentiated from 
transcripts isolated at 6 h p.i. without the use of PAA (Fig. 2 C, lane 3). Spe- 
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Fig. 2. Effect of metabolic inhibitors on Cooper BHV- 1 DNA and RNA synthesis. A Infected 
cell DNAs at 0, 2.5, 4.5, 6.5, and 8 h post infection (p.i.) (1) and in the presence of 50, 100, 
or 150 ~tg/ml cycloheximide at 5 h p.i. or 200, 300, or 400 gg/ml phosphonoacetic acid at 
6h p.i. (2) were slot-blotted and hybridized with radioactivity labeled BHV-1 genomic 
DNA. B Blot hybridization of total infected cell RNA with radioactively labeled HindIII 
D fragment at 50 (1), I00 (2), or 150 (3) gg/ml of cycloheximide. C Blot hybridization of 
total infected cell RNA in the presence of 400 txg/ml phosphonoacetic acid with radioactively 
labeled HindIII I fragment at 6 (1) and 8 h (2) p.i. 3 Total infected cell RNA at 6 h p.i. 
with no metabolic inhibitors and hybridized with radioactivity labeled HindIII fragment I 
(3). Molecular size markers in kilobases are noted to the left of B and C 
cifically, a 6.5 kb late R N A  was clearly visible (Fig. 2 C, lane 3) at 6 h p.i. without 
the use of PAA as compared to R N A  purified from cells treated with PAA 
(Fig. 2 C, lanes 1 and 2). A 0.6 kb early R N A  was present in the R N A  isolated 
from cells treated with PAA (Fig. 2 C, lanes 1 and 2), but was not detected by 
8 h p.i. (Fig. 2 C, lane 3). 
Identification of immediate-early transcripts 
To identify immediate-early transcripts, BHV-1 infected cellular R N A  was 
isolated at 5 h p.i. following treatment of infected cells with 100 txg/ml CH. The 
R N A  was analyzed by Northern blot hybridization with radioactively labeled 
fragments from the BHV-1 genome. Following temporal analysis of R N A  
production during active infections in cell culture and analysis of BHV- 1 R N A  
production in the presence of  CH, three immediate-early transcripts were iden- 
tified using the HindIII D fragment (Fig. 5 and Table 1). The HindIII D fragment 
encompasses the internal inverted repeat section of the BHV-1 genome from 
Fig. 3. Blot hybridization analysis of transcripts in BHV-1 Cooper infected cells synthesized 
from map units 0.018 to 0.195 of the unique long component of the virus genome. Total 
infected celt RNA was fractionated by glyoxal gel electrophoresis and transferred to nylon 
filters. Viral RNA was detected by hybridization with 32p-labeled BHV-1 DNA from cloned 
HindIII fragments J, M, and I followed by autoradiography, a RNA purified from BHV- 
1 infected cells treated with 100 gg/ml cycloheximide (C), 400 gg/ml phosphonoacetic acid 
(P) or at 6 h post infection (p.i.) without drug treatment (6). b RNA purified at various 
times (h) p.i. as indicated above each lane. Molecular size markers in kilobases are noted 
to the left of each panel. The size and classification of each viral RNA is in the right-hand 
margin of each panel and designated as early (E) or late (L) based upon its detection in 
the presence or absence of phosphonoacetic acid and its time of appearance 
Fig. 4. Blot hybridization analysis of transcripts in BHV-1 Cooper infected cells synthesized 
from map units 0.195 to 0.537 of the unique long region of the virus genome. Viral RNA 
was detected by hybridization with 32p-labeled BHV- 1 DNA from cloned HindIII fragments 
E, G, and A followed by autoradiography, a RNA purified from BHV-1 infected cells 
treated with 100 gg/mt cycloheximide (C), 400 gg/ml phosphonoacetic acid (P) or at 6h 
post infection (p.i.) without drug treatment (6). b RNA purified at various times (h) p.i. 
as indicated above each lane; U uninfected cell control. Molecular size markers in kilobases 
are noted to the left of each panel. The size and classification of each viral RNA is in the 
right-hand margin of each panel and designated as early (E) or late (L) b~tsed upon its 
detection in the presence or absence of phosphonoacetic acid and its time of appearance 
Fig. 5. Blot hybridization analysis of transcripts in BHV-1 Cooper infected cells synthesized 
from map units 0.537 to 0.842, covering portions of the unique long, internal inverted 
repeat and unique short components of the virus genome. Viral RNA was detected by 
hybridization with 32p-labeled BHV-1 DNA from cloned HindIII fragments B, L, and D 
followed by autoradiography, a RNA purified from BHV-1 infected cells treated with 
100 ~tg/ml cycloheximide (C), 400 gg/ml phosphonoacetic acid (P) or at 6 h post infection 
(p.i.) without drug treatment (6). b RNA purified at various times (h) p.i. as indicated 
above each lane. Molecular size markers in kilobases are noted to the left of each panel. 
The size and classification of each viral RNA is in the right-hand margin of each panel 
and designated as immediate-early (IE), early (E) or late (L) based upon detection in the 
presence or absence of cycloheximide or phosphonoacetic acid and its time ,of appearance 
Fig.6. Blot hybridization analysis of transcripts in BHV-1 Cooper infected bovine cells 
synthesized from map units 0.842 to 1.000 of the unique short and terminal repeat com- 
ponents of the virus genome. Viral RNA was detected by hybridization with 32p-labeled 
BHV-1 DNA represented by the cloned HindIII fragments O and K and the EcoRI F 
fragment followed by autoradiography, a RNA purified from BHV-1 infected cells treated 
with 100 ~tg/ml cycloheximide (C), 400 ~tg/ml phosphonoacetic acid (P) or at 6 h post in- 
fection (p.i.) without drug treatment (6). b RNA purified at various times (h) p.i. as indicated 
above each lane. Molecular size markers in kilobases are noted to the left of each panel. 
The size and classification of viral RNA is in the right-hand margin of each panel by 
molecular size and designated as early (E) or late (L) based upon its detection in the presence 
or absence of phosphonoacetic acid and its time of appearance 
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Fig. 7. Blot hybridization analysis of transcripts in BHV-1 Cooper infected bovine cells 
synthesized from map units 0.734 to 0.778 of the internal inverted repeat sequences of the 
virus genome. Viral RNA was detected by hybridization with 32p-labeled BHV-I DNA 
represented by cloned HS (0.734-0.748 m.u.) and HK (0.734-0.778 m.u.) probes of the 
HindIII D fragment followed by autoradiography. The panels represent RNA purified at 
various times (h) p.i. as indicated above each lane. Molecular size markers in kilobases are 
noted to the left of each panel. Viral RNA is designated as immediate-early (IE) in the 
right margin of each panel by molecular size 
map units 0.734 to 0.842 (Fig. 1). In the presence of CH, transcripts of 2.1, 3.4, 
and 5.8 kb were detected (Fig. 5 a, D, lane C). Temporal analysis of BHV-1 
infected celt RNA hybridizing to the D fragment at various times p.i. (Fig. 5 b, 
D) demonstrates that all three transcripts appear in greatest abundance at 3 h 
p.i. and then steadily decline later during the BHV-1 infection of cells in culture. 
No other transcripts were readily identified with any of the other cloned frag- 
ments or with the terminal fragment of the BHV-1 genome when hybridized 
to RNA isolated from BHV-1 infected cells in the presence of CH. 
To further characterize from which area of the genome the IE transcripts 
were synthesized, two subclones from the D fragment designated HS and H K  
were used as probes at various times p.i. (Fig. 7). The HS probe representing 
0.734 to 0.748 m.u. recognized one 3.4kb RNA at 3h p.i. and at 6h  p.i., but 
not at 8 h p.i. The HK probe (0.734 to 0.778 m.u.), which includes the region 
of the genome encompassed by the HS probe, recognized the 3.4 kb RNA and 
an additional 5.8 kb RNA at the same time points as the HS probe (Fig. 7). 
Both of  these transcripts were detected using the entire HindIII D fragment. It 
appears that the 3.4 kb and 5.8 kb transcripts are synthesized from the left end 
of the D fragment, while the 2.1 kb immediate-early RNA may be transcribed 
from the right terminus of  the D fragment. 
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Table 1. Size, classification, and location of transcripts fi'om the genome of the BHV-1 
Cooper isolate ~ 
J M I E G A B L D O K Eco F 
9.4, L 7.3, L 6.5, L b 9.0, L 10.0, L 6.0, E 7.0, L 9.0, L 5.8, IE 2.8, L 6.5, L 
7.4, E 6.5, L b 4.5, E c 8.5, L 5.5, E 4.5, E 2.2, L 5.0, L 3.4, IE 1.8, E 4.0, E 
3.6, E 4.6, E c 3.8, E 8.0, L 4.3, E 4.0, E 1.5, E 3.4, L 2.1, IE 3.5, E 
2.4, E 2.5, E 2.6, E 4.1, L 1.6, E 3.5, E 2.8, E 1.6, L 2.2, E 
2.2, E 2.0, L 2.1, L 1.8, E 0.8, L 1.6, L 1.8, L 2.0, E 







5E 2E 5E 1E 3E 4E 1E IE 3IE 1E 5E 4L 
1L 3L 3L 4L 2L 1L 2L 5L 1L 1L 1L 
a Transcript sizes in kilobases were determined by extrapolation between the relative 
mobilities of the RNA size markers. Classification and location of transcripts were assigned 
by their detection during cycloheximide treatment (IE immediate-early), phosphono- 
acetic acid treatment (E early), or no drug treatment (L late) and hybridization with the 
specific HindIII fragment listed or the EcoRI F fragment 
b,c Specific RNAs of similar size and temporal classification which were detected by 
two different fragments, possibly due to transcription across a restriction enzyme site 
Identification of early transcripts 
For detection of early transcripts, RNA was isolated from BHV-1 infected cells 
with PAA at 6 h p.i. Twenty-eight early transcripts were detected across the 
BHV-1 genome using all the cloned HindIII fragments except the HindIII D 
fragment (Table 1). Twelve early transcripts were identified using the HindIII 
fragments J, M, and I (Fig. 3 and Table 1) encompassing 0.018 to 0.195 m.u. 
of the BHV-1 genome (Fig. 1). 
Specifically, five early transcripts of 1.8, 2.2, 2.4, 3.6, and 7.4 kb were detected 
using the J fragment, two 2.6 and 4.6 kb early transcripts were identified using 
the HindIII M fragment (Fig. 3 and Table 1) and five early transcripts detected 
using the HindIII I fragment were 0.6, 1.2, 2.6, 3.8, and 4.5kb in size. The 
4.6 kb RNA listed as arising from the M fragment and the 4.5 kb RNA detected 
using the I fragment quite possibly were synthesized across the restriction en- 
zyme site (Table 1). This conclusion was substantiated by comparison of the 
time course of their appearance in BHV-1 infected cell RNA (Fig. 3b, M and 
I). 
From the HindIII E, G, and A fragments (Fig. 4 and Table 1) comprising 
0.195 to 0.537 m.u. of the unique long component of the BHV-1 genome (Fig. 1), 
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eight early transcripts were identified. A single 1.8 kb early RNA was detected 
using the E fragment, while three early transcripts of 1.6, 4.3, and 5.5 kb were 
identified with the G fragment. Four early transcripts of 3.5, 4.0, 4.5, and 6.0 kb 
were detected by the HindIII A fragment of the BHV-1 genome (Fig. 4 and 
Table 1). Analysis of the temporal appearance of these transcripts (Fig. 4b, E, 
G, and A), along with the appearance of each individual RNA in the presence 
of PAA (Fig. 4a, E, G, and A), indicates that these are individual transcripts 
arising from within the area of the genome represented by each fragment with 
none appearing to cross HindIII restriction enzyme sites. 
The area of the genome from 0.537 to 0.842 m.u., covering portions of the 
unique long, the internal inverted repeat, and into the unique short region of 
the genome, is represented by the HindIII fragments B, L, and D (Fig. 1). From 
this region of the genome only two early transcripts were identified. Using the 
B fragment, a 1.5 kb early RNA was detected, and a 2.8 kb early RNA was 
synthesized from the L fragment (Fig. 5 and Table 1). The appearance of these 
transcripts in the presence of PAA (Fig. 5a) and at various times p.i. (Fig. 5b) 
is consistent with the definition of early transcripts. 
Early transcripts arising from the area of the BHV-1 genome from 0.842 to 
1.000 m.u. of the Us component of the BHV-1 genome were identified using 
the HindIII 0 and K fragments along with the EcoRI fragment F (Fig. 1). A 
1.8 kb early RNA was detected using the O fragment, while five early transcripts 
of 1.3, 2.0, 2.2, 3.5, and 4.0kb were detected using the HindlII K fragment 
(Fig. 6 and Table 1). No early transcripts were found using the terminal EcoRI 
F fragment as a probe (Fig. 6 and Table 1). 
Identification of late transcripts 
A total of 28 late transcripts were identified throughout the entire BHV-1 
genome. These transcripts were identified by their appearance late (6-8 h p.i.) 
during the BHV-1 infection and in the absence of metabolic inhibitors. Seven 
late transcripts were identified using the cloned HindIII fragments J, M, and I 
(Fig. 3 and Table 1) representing 0.018 to 0.195 m.u. of the BHV-1 genome 
(Fig. 1). A 9.4 kb late RNA was detected using the J fragment, while 6.5 and 
2.0kb transcripts were identified using the M fragment (Fig. 3 and Table 1). 
The largest number of transcripts was detected using the I fragment (Fig. 3 and 
Table 1) and of these, three were classified as late. The 1.8 and 2.1 kb RNAs 
of the I fragment appear to be transcribed exclusively from within the I fragment. 
However, the 6.5 kb late RNA may be shared by the M fragment (Fig. 3 and 
Table 1). 
Transcription from the unique long section of the BHV-1 genome encom- 
passing map units 0.195 to 0.537 was analyzed by RNA blot hybridization 
using the HindIII restriction fragments E, G, and A (Fig. 4 and Table 1). Tran- 
scripts identified using fragment E were 4.1, 8.0, 8.5, and 9.0 kb in size (Fig. 4). 
From the G fragment two late RNAs of 0.8 and 10.0 kb were detected without 
the use of PAA (Fig. 4a, G). A single 1.6kb late RNA was identified within 
68 B.S. Seal etal. 
the A fragment which contained predominantly early transcripts (Fig. 4 and 
Table 1). 
Using the HindIII B, L, and D fragments encompassing the "far right" of 
the unique long, the inverted repeat and into the unique short region of the 
BHV-1 genome (0.537 to 0.842 m.u.) seven late transcripts were identified (Fig. 5 
and Table 1). Two late RNAs of 2.2 and 7.0 kb were detected with the HindIII 
B fragment. Using the L fragment for RNA blot hybridization, five late tran- 
scripts could be identified with sizes of 1.0, 1.8, 3.4, 5.0, and 9.0 kb. However, 
a 1.6kb late RNA was identified using the D fragment (Fig. 5 and Table 1). 
Since neither the HS or HK probes from the left terminus of the D fragment 
detect this RNA (Fig. 7), it may be inferred that this 1.6 kb late RNA is tran- 
scribed from the right side of:the D fragment. 
Transcription from the unique short section of the BHV-I genome from 
map units 0.842 to 1.0 was investigated using the HindIII fragments O and K 
and the EcoRI F fragment (Fig. 1). One 2.8 kb late RNA was detected with the 
O fragment. Using the K fragment, which primarily codes for early transcripts, 
a single 6.5 kb late RNA was identified (Fig. 6 and Table 1). The right terminus 
of the BHV-1 Cooper genome is represented by the EcoRI F fragment (Fig. 1) 
and four late transcripts were identified as being synthesized from this section 
of the genome (Fig. 6 and Table 1). These transcripts were 1.9, 2.2, 3.2, and 
5.4 kb in size. 
Discussion 
Fifty-nine transcripts ranging in size from 0.6 to 10 kb were detected during a 
productive infection of bovine cells in culture by the BHV-1 Cooper isolate. 
These transcripts were categorized into three temporal classes based upon two 
sets of criteria. Analysis was organized by the ability to detect individual tran- 
scripts from infected cells treated specifically with CH, PAA, or without drug 
treatment. Appearance of specific transcripts was also monitored temporally 
during a BHV-1 infection of cells in culture. Such a thorough examination of 
BHV-1 transcription has enabled us to unequivocally characterize individual 
transcripts. The number of transcripts and classification scheme are similar to 
results obtained using cloned double-stranded viral genomic DNA probes for 
vaficella zoster virus [40, 43], herpes simplex virus type 1 (HSV-1; [60]) and 
equine herpesvirus t [ 16]. The 59 transcripts are five greater than the 54 tran- 
scripts reported previously for BH¥-I [58-1. This may be due to the fact that, 
during the studies reported here, the terminal EcoRI F fragment was also used 
to identify four additional transcripts. 
Using the metabolic inhibitor CH, three immediate-early transcripts were 
identified as being synthesized from the inverted repeat region of the BHV-1 
genome at (0.734 to 0.842 m.u.) encompassing the HindIII D fragment. In this 
study the sizes were determined to be 2.1, 3.4, and 5.8 kb, whereas three im- 
mediate-early transcripts were previously reported to be 1.6, 2.9, and 4.2 kb in 
size [58]. The HS probe covering the left terminus of the HindlII D fragment 
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(0.734 to 0.748 m.u.) corresponds to the area of the BHV-1 genome where 
latency-associated transcription occurs 1-44]. Using this fragment, a 3.4 kb RNA 
was detected. A larger fragment, the HK probe (0.734 to 0.778 m.u.), detected 
the 3.4 kb RNA, and an additional 5.8 kb immediate-early RNA. Results using 
the HS and HK probes indicate that these two transcripts arise from the left 
side of the D fragment, while the 2.1 kb immediate-early RNA and the 1.6 kb 
late RNA arise from the right side of the HindIII D fragment. A fourth im- 
mediate-early transcript of 1.8 kb was also reported in this region of the genome 
[58]. During the investigations reported here a 1.6 kb transcript was identified, 
but found not to be produced in the presence of CH and only at late times 
during infection. 
Using the herpesvirus DNA polymerase inhibitor PAA [26], 28 transcripts 
were categorized in the early class. An earlier study demonstrated a greater 
resistance of BHV-1 to PAA than other herpesviruses [1]. Consequently, op- 
timum concentrations of PAA were determined and a concentration of 400 gg/ 
ml PAA was used to identify the early transcripts. As with other herpesviruses, 
early transcription was not limited to specific areas of the genome [16, 40, 60]. 
A number of early genes have now been mapped and their location within the 
BHV-1 genome corresponds to areas where clusters of early transcripts were 
identified during this study. The gI (gB homologue of HSV) gene of BHV-1 
has been localized from 0.405 to 0.432 m.u. [24, 38, 57] and the thymidine 
kinase gene has been placed at map units 0.470 to 0.480 [39] of the BHV-1 
Cooper HindIII A fragment (0.381 to 0.537). Five early transcripts ranging in 
size from 3.5 kb to 6.0 kb were detected using the A fragment for RNA blot 
hybridization. Specifically, a transcript of 4.5 kb was identified that is equivalent 
to the size estimate of the transcript from the cloned BHV-1 TK gene (L. J. 
Bello, University of Pennsylvania, Philadelphia, PA, pets. comm.). This 4.5 kb 
early transcript was unreported from this area of the genome in earlier work 
[58]. Two other early genes that have been identified include the BHV-1 DNA 
polymerase gene at map units 0.334 to 0.352 [41] and a putative DNA binding 
protein gene localized from map units 0.352 to 0.381 [2] within the HindIII G 
fragment of BHV-1 Cooper (0.294 to 0.381). Three early transcripts have been 
identified in this region during these studies. Size estimates of the DNA po- 
lymerase and DNA binding protein genes [2, 4] of BHV-t correspond to the 
1.6kb and 4.3 kb early RNAs described here. Both the HindIII I fragment 
(0.110 to 0.195 m.u.) of the unique long and the HindIII K fragment (0.845 to 
0.907 m.u.) of the unique short areas of the BHV-1 genome contained clusters 
of early transcripts. Unlike a previous report [58], we show that the HindIII 
I fragment coded for the greatest number of transcripts from the BHV- 1 genome 
and the sizes of transcripts reported herein are larger. Glycoprotein gIV (gD 
homologue of HSV) mapped to the HindlII K fragment between 0.892 and 
0.902 m.u. [53]. In addition to gIV, preliminary investigations have demon- 
strated the K fragment also codes for a cluster of glycoprotein genes including 
gE, gI, and gX/G (T. Zamb, Veterinary Infectious Disease Organization, Uni- 
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versity of Saskatchewan, Saskatoon, Saskatchewan, pers. comm.) in a situation 
similar to HSV-1 [60]. 
In the absence of metabolic inhibitors and based upon detection of individual 
RNAs following the initiation of BHV-1 DNA synthesis at 4 to 5 h p.i., 28 late 
transcripts were identified. As in early gene expression, late transcripts were 
located throughout the genome. However, the HindIII E fragment (0.195 to 
0.294 m.u.) and the HindIII L fragment (0.678 to 0.734 m.u.) of the unique 
long section of the BHV-1 genome recognized predominantly late RNA. The 
EcoRI F fragment (0.936 to 1.0 m.u.) representing the right terminus of the 
BHV-1 genome recognized only transcripts of the late class. One late 1.6kb 
RNA was detected using the HindIII D fragment, which otherwise recognized 
primarily immediate-early RNA. The glycoprotein gIII (gC) gene of BHV-1 
has been cloned, sequenced, and the gene has been localized at map units 0.122 
to 0.135 m.u. of the HindIII I fragment [12, 13]. The gIII gene is approximately 
1.6 kb in size 1-12] and most likely corresponds to the 1.8 kb late RNA recognized 
by the I fragment during this investigation. Preliminary data using the cloned 
BHV-1 gIII gene have confirmed this (unpubl.). In previous transcriptional 
studies only 12 transcripts were identified as possibly belonging to the late class 
[58]. Using metabolic inhibitors along with temporal analysis of BHV-1 RNA 
synthesis, 28 late transcripts were specifically identified during these investi- 
gations. 
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